These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 20081091)

  • 1. PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans.
    Soond DR; Bjørgo E; Moltu K; Dale VQ; Patton DT; Torgersen KM; Galleway F; Twomey B; Clark J; Gaston JS; Taskén K; Bunyard P; Okkenhaug K
    Blood; 2010 Mar; 115(11):2203-13. PubMed ID: 20081091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.
    Aragoneses-Fenoll L; Montes-Casado M; Ojeda G; Acosta YY; Herranz J; Martínez S; Blanco-Aparicio C; Criado G; Pastor J; Dianzani U; Portolés P; Rojo JM
    Biochem Pharmacol; 2016 Apr; 106():56-69. PubMed ID: 26883061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p110δ subunit of PI3K regulates bone marrow-derived eosinophil trafficking and airway eosinophilia in allergen-challenged mice.
    Kang BN; Ha SG; Ge XN; Reza Hosseinkhani M; Bahaie NS; Greenberg Y; Blumenthal MN; Puri KD; Rao SP; Sriramarao P
    Am J Physiol Lung Cell Mol Physiol; 2012 Jun; 302(11):L1179-91. PubMed ID: 22427531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Phosphoinositide 3-Kinase p110delta Does Not Affect T Cell Driven Development of Type 1 Diabetes Despite Significant Effects on Cytokine Production.
    Barbera Betancourt A; Emery JL; Recino A; Wong FS; Cooke A; Okkenhaug K; Wallberg M
    PLoS One; 2016; 11(1):e0146516. PubMed ID: 26783747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice.
    Durand CA; Richer MJ; Brenker K; Graves M; Shanina I; Choi K; Horwitz MS; Puri KD; Gold MR
    Autoimmunity; 2013 Feb; 46(1):62-73. PubMed ID: 23039284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model.
    Lee KS; Lee HK; Hayflick JS; Lee YC; Puri KD
    FASEB J; 2006 Mar; 20(3):455-65. PubMed ID: 16507763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy.
    Law AJ; Wang Y; Sei Y; O'Donnell P; Piantadosi P; Papaleo F; Straub RE; Huang W; Thomas CJ; Vakkalanka R; Besterman AD; Lipska BK; Hyde TM; Harrison PJ; Kleinman JE; Weinberger DR
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12165-70. PubMed ID: 22689948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 13 increases contractility of murine tracheal smooth muscle by a phosphoinositide 3-kinase p110delta-dependent mechanism.
    Farghaly HS; Blagbrough IS; Medina-Tato DA; Watson ML
    Mol Pharmacol; 2008 May; 73(5):1530-7. PubMed ID: 18276774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of PI3Kδ Enhances Poly I:C-Induced Antiviral Responses and Inhibits Replication of Human Metapneumovirus in Murine Lungs and Human Bronchial Epithelial Cells.
    Fujita A; Kan-O K; Tonai K; Yamamoto N; Ogawa T; Fukuyama S; Nakanishi Y; Matsumoto K
    Front Immunol; 2020; 11():432. PubMed ID: 32218789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phosphoinositide 3'-kinase p110δ modulates contractile protein production and IL-6 release in human airway smooth muscle.
    Ge Q; Moir LM; Trian T; Niimi K; Poniris M; Shepherd PR; Black JL; Oliver BG; Burgess JK
    J Cell Physiol; 2012 Aug; 227(8):3044-52. PubMed ID: 22015454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses.
    Durand CA; Hartvigsen K; Fogelstrand L; Kim S; Iritani S; Vanhaesebroeck B; Witztum JL; Puri KD; Gold MR
    J Immunol; 2009 Nov; 183(9):5673-84. PubMed ID: 19843950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 3-Kinase p110δ Isoform Regulates CD8+ T Cell Responses during Acute Viral and Intracellular Bacterial Infections.
    Gracias DT; Boesteanu AC; Fraietta JA; Hope JL; Carey AJ; Mueller YM; Kawalekar OU; Fike AJ; June CH; Katsikis PD
    J Immunol; 2016 Feb; 196(3):1186-98. PubMed ID: 26740110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p110 delta isoform of phosphatidylinositol 3-kinase controls the quality of secondary anti-Leishmania immunity by regulating expansion and effector function of memory T cell subsets.
    Liu D; Uzonna JE
    J Immunol; 2010 Mar; 184(6):3098-105. PubMed ID: 20154209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway.
    Chetoui N; Boisvert M; Gendron S; Aoudjit F
    Immunology; 2010 Jul; 130(3):418-26. PubMed ID: 20465565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic or pharmaceutical blockade of p110delta phosphoinositide 3-kinase enhances IgE production.
    Zhang TT; Okkenhaug K; Nashed BF; Puri KD; Knight ZA; Shokat KM; Vanhaesebroeck B; Marshall AJ
    J Allergy Clin Immunol; 2008 Oct; 122(4):811-819.e2. PubMed ID: 19014771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3Kδ Forms Distinct Multiprotein Complexes at the TCR Signalosome in Naïve and Differentiated CD4
    Luff DH; Wojdyla K; Oxley D; Chessa T; Hudson K; Hawkins PT; Stephens LR; Barry ST; Okkenhaug K
    Front Immunol; 2021; 12():631271. PubMed ID: 33763075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of phosphoinositide 3-kinase p110α preserves lymphocyte function.
    So L; Yea SS; Oak JS; Lu M; Manmadhan A; Ke QH; Janes MR; Kessler LV; Kucharski JM; Li LS; Martin MB; Ren P; Jessen KA; Liu Y; Rommel C; Fruman DA
    J Biol Chem; 2013 Feb; 288(8):5718-31. PubMed ID: 23275335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16.
    Billottet C; Grandage VL; Gale RE; Quattropani A; Rommel C; Vanhaesebroeck B; Khwaja A
    Oncogene; 2006 Oct; 25(50):6648-59. PubMed ID: 16702948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphoinositide 3-Kinase p110 Delta Differentially Restrains and Directs Naïve Versus Effector CD8
    Spinelli L; Marchingo JM; Nomura A; Damasio MP; Cantrell DA
    Front Immunol; 2021; 12():691997. PubMed ID: 34220851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PI3K p110δ activity reduces IgE production in IL-4 and anti-CD40 stimulated human B cell cultures.
    Cutrina-Pons A; De Sa A; Fear DJ; Gould HJ; Ramadani F
    Immunology; 2023 Dec; 170(4):483-494. PubMed ID: 37530226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.